Evidence map›Paper›PMID 30672465›Full record

ArticleeLife2019

Dynein-mediated transport and membrane trafficking control PAR3 polarised distribution.

Julie Jouette, Antoine Guichet, Sandra B Claret

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Polarity Events in theFrontiers in cell and developmental biology · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julie JouetteInstitut Jacques Monod, CNRS, UMR 7592, Paris Diderot University, Sorbonne Paris Cité, Paris, France.ORCID 0000-0002-0115-0065
Antoine GuichetInstitut Jacques Monod, CNRS, UMR 7592, Paris Diderot University, Sorbonne Paris Cité, Paris, France.ORCID 0000-0001-7216-1944
Sandra B ClaretInstitut Jacques Monod, CNRS, UMR 7592, Paris Diderot University, Sorbonne Paris Cité, Paris, France.ORCID 0000-0001-7167-510X

Funding

Fondation ARC pour la Recherche sur le Cancer PJA 20141201756Fondation ARC pour la Recherche sur le Cancer PJA 20161204931Fondation ARC pour la Recherche sur le Cancer SLR20130607102Ligue Contre le Cancer RS14/75-58
6 · The paper itself

Abstract

The scaffold protein PAR3 and the kinase PAR1 are essential proteins that control cell polarity. Their precise opposite localisations define plasma membrane domains with specific functions. PAR3 and PAR1 are mutually inhibited by direct or indirect phosphorylations, but their fates once phosphorylated are poorly known. Through precise spatiotemporal quantification of PAR3 localisation in the

Indexed as

Cell PolarityAnimalsBody PatterningCell MembraneCytoskeletonDrosophila melanogasterDrosophila ProteinsDyneinsEndocytosisIntracellular Signaling Peptides and ProteinsOocytesPhosphatidylinositol 4,5-DiphosphateProtein BindingProtein Transportbaz protein, DrosophilaDrosophila ProteinsDyneinsIntracellular Signaling Peptides and ProteinsPhosphatidylinositol 4,5-Diphosphatecell biologyD. melanogasterDyneinIKKePAR3phosphoinositidesPIP5KRAB11

Identifiers

PMID30672465
PMCPMC6358217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.